Ubs Group Ag Pmv Pharmaceuticals, Inc. Put Options Transaction History
Ubs Group Ag
- $452 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding PMVP
# of Institutions
83Shares Held
41.9MCall Options Held
3.1KPut Options Held
1.7K-
Orbimed Advisors LLC San Diego, CA6.48MShares$10.4 Million0.23% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO3.65MShares$5.87 Million0.08% of portfolio
-
Sio Capital Management, LLC New York, NY3.21MShares$5.17 Million2.53% of portfolio
-
Euclidean Capital LLC New York, NY2.63MShares$4.23 Million0.43% of portfolio
-
Alkeon Capital Management LLC New York, NY2.34MShares$3.77 Million0.01% of portfolio
About PMV Pharmaceuticals, Inc.
- Ticker PMVP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,622,600
- Market Cap $73.5M
- Description
- PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...